CONCLUSIONS: Nightly delayed-release methylphenidate was associated with meaningful improvement in early morning sleep inertia and brain fog severity in the majority of this small pediatric cohort with symptoms refractory to standard therapy. Larger, controlled studies are needed to establish efficacy, optimal dosing, and patient selection criteria.
